Clinical Trials · NCT00949962
Post-operative or Early Salvage XRT and ADT for High Risk PCa
- Phase
- Phase 3
- Recruitment status
- Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Enrollment
- 87
- Start date
- Oct 2009
- Locations
- 1 site, France
- Primary endpoint
- Biochemical progression-free survival